
Air New Zealand Raises Fares as Middle East Conflict Drives Jet Fuel Prices Higher
Mar 10, 2026 05:34 am UTC| Business
Air New Zealand has announced fare increases across its network following a dramatic surge in jet fuel costs triggered by the U.S.-Israeli war on Iran. The New Zealand flag carrier confirmed economy fares have risen by...

Goldman Sachs Offers Hedge Funds Tools to Short AI-Threatened Corporate Loans
Mar 10, 2026 05:31 am UTC| Business Insights & Views
Goldman Sachs is quietly approaching hedge funds with sophisticated strategies to bet against corporate loans, responding to a surge in demand for short positions targeting enterprise software companies under pressure from...

Chinese Electric Freight Trucks Are Disrupting Europe's Market in 2026
Mar 10, 2026 05:20 am UTC| Business Economy
A wave of Chinese electric freight trucks is entering Europe in 2026, bringing advanced technology and competitive pricing that could reshape the continents commercial vehicle landscape. Reuters has identified over half a...

Yann LeCun's AI Startup AMI Raises $1 Billion at $3.5 Billion Valuation
Mar 10, 2026 05:18 am UTC| Business Technology
Advanced Machine Intelligence (AMI), the artificial intelligence startup founded by renowned AI researcher and former Meta Platforms chief AI scientist Yann LeCun, has successfully closed a $1.03 billion funding round...

Mar 09, 2026 09:26 am UTC| Business
Amalga Groups Jens Erik Gould explains how nearshore BPO is shifting toward managed delivery models built around accountability, measurable outcomes, and AI-enabled execution. Outsourcing models are evolving as companies...

Nvidia Sets $4M CEO Bonus Target for Fiscal 2027 as AI Demand Drives Revenue Growth
Mar 07, 2026 05:07 am UTC| Business Technology
NVIDIA Corporation (NASDAQ: NVDA) has introduced a new variable compensation plan for fiscal 2027 that ties executive bonuses directly to revenue performance, according to a recent regulatory filing. Under the updated...

FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
Mar 07, 2026 05:05 am UTC| Health Governance Business
Dr. Vinay Prasad, the controversial director of the U.S. Food and Drug Administrations Center for Biologics Evaluation and Research (CBER), will step down from his role at the end of April, according to FDA Commissioner...